Experienced in Hydrocephalus

Chul-kee K. Park

Seoul, KR 
Experienced in Hydrocephalus
Seoul, KR 
OverviewLocationsClinical Research

Overview

Chul-kee Park practices in Seoul, Republic of Korea. Park is rated as an Experienced expert by MediFind in the treatment of Hydrocephalus. Their top areas of expertise are Glioma, Gliomatosis Cerebri, Astrocytoma, Osteotomy, and Gamma Knife Radiosurgery.

Their clinical research consists of co-authoring 316 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Hydrocephalus.

Locations

Seoul, Republic of Korea
Other Locations
Gyeonggi-do, Republic of Korea
Songnam, Republic of Korea
Wondu, Republic of Korea
Gwangju, Republic of Korea
Wide River Institute Of Immunology, Hongch'on, Republic of Korea
Chuncheon, Republic of Korea
Incheon, Republic of Korea
Korean Society For Neuro Oncology, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3

316 Total Publications

Histopathologic risk factors for progression of atypical meningioma: a retrospective cohort study evaluating the impact and clinical value of mitotic count and Ki-67.
Histopathologic risk factors for progression of atypical meningioma: a retrospective cohort study evaluating the impact and clinical value of mitotic count and Ki-67.
Journal: Acta neurochirurgica
Published: July 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Park's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 33 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile